Latest News

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Expert can speak on the promise of vaccines to counter heroin addiction and broader efforts to address opioid addiction. Roger Crystal, M.D., CEO of Opiant Pharmaceuticals, has an interest in this area inspired by his company’s own efforts to develop opioid antagonist nasal sprays and other innovative formulations for the treatment of substance abuse disorders, addictive disorders and eating disorders.

• share
• favorite_border

Expert can speak on the use of animal toxins to develop a new generation of medicines. Gur Roshwalb, MD, Chief Executive Officer of Akari Therapeutics, is studying the use of Coversin—a molecule derived from the saliva of the Ornithodoros moubata tick—in potential treatments for conditions such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and Guillain Barré syndrome (GBS).

• share
• favorite_border

Expert can speak on the importance of including women in clinical studies, a measure that could lead to improved, women-specific treatments. Brad Thompson, Ph.D., president and CEO of Oncolytics Biotech Inc., has overseen studies in colorectal cancer and non-small cell lung cancer in which female patients showed a significant response (relative to male patients) to a treatment that included the company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus.

• share
• favorite_border

Expert can speak about the need for better treatment of complex regional pain syndrome (CRPS), a chronic condition most often affecting one of the limbs (arm, leg, hand or foot), usually after an injury or trauma to that limb. Randall Kaye, M.D. of Axsome Therapeutics can describe the characteristics of CRPS, discuss the many stories from patients describing their pain, and detail a clinical study Axsome is conducting a study on what could be the first-ever approved medication for the condition.

• share
• favorite_border

Expert can speak on the use of EEG measurements to predict how individuals will respond to specific medical treatments. Specifically, MYnd Analytics has developed the PEER Online platform, allowing doctors to compare patients’ EEGs to a growing database that correlates specific EEG patterns with positive and negative responses to a range of psychotropic medications. As a result, doctors can use evidence-based medicine to reduce the traditional “trial and error” approach to prescribing for mental health.

• share
• favorite_border

Expert can discuss recent advances in the science of bioanalytics and molecular information, that let us identify and characterize the products of all living cells—including proteins, lipids, metabolites and nucleic acids. He can specifically focus on how this technology is becoming a key driver in basic research, pharmaceutical development and clinical medicine.

• share
• favorite_border

Experts can speak on the factors contributing to the rise in popularity of walk-in urgent care and primary care centers across the U.S., as well as the future growth of this sector and the business potential associated with consolidation among urgent care networks.

• share
• favorite_border

Expert can discuss the potential synergies between CRISPR (and other gene editing tools) and the AdenoVerse gene delivery technology platform developed by GenVec, Inc. The AdenoVerse platform has demonstrated an outstanding ability to deliver complex genes and works with a variety of strategies for therapeutics and vaccines, including gene editing tools—not only CRISPR but also TALEN, Zinc Finger, ARCUS and others.

• share
• favorite_border

After Cynthia Vetter’s husband—a highway patrol officer—was fatally shot in Texas during a routine traffic stop in 2000, the tragedy inspired the creation of Dallas-based COPsync, Inc. The company has created the COPsync Network, with applications that enable law enforcement patrol officers to communicate in real-time on the Network; and COPsync911, which is activated by school staff when a threatening situation arises, and allows the staff to send an immediate and silent alert to all other staff, the local law enforcement dispatch center and the closest law enforcement officers in their patrol cars.

• share
• favorite_border

Expert can discuss drone package delivery and why launching delivery drones from local delivery trucks can make the drone flights short, effective, safe and extremely economical.

• share
• favorite_border

Expert can discuss the ways in which industries that produce low-BTU waste gases (such as methane) can remain profitable even while adopting the EPA’s new Clean Power Plan, and how the technology developed by his company, Ener-Core, Inc., can play a key role in effective this positive change.

• share
• favorite_border

Expert can speak about the need for better technological solutions to keep law enforcement officers safe to help them interdict criminals traveling throughout the U.S., as well as systems such as the COPsync Network that are already in use in various states.

• share
• favorite_border

Expert can discuss the need to address the issue of heroin and prescription opioid abuse by developing innovative medical treatments. Specifically, he can describe the features and benefits of an inside-the-cheek format of buprenorphine for the maintenance treatment of opioid addiction.